Study reveals propolis potential for metabolic disorder patients

A recent clinical study shows that HDI Propoelix propolis extract can support the immune system in patients with metabolic disorders such as diabetes, obesity, and hypertension. The 30-day study was conducted at RS Soerojo Magelang and presented at a seminar in Jakarta on March 7, 2026. Experts emphasize that the supplement serves only as a complement, not a replacement for medical therapy.

The 25th clinical study by HDI Propoelix, recently published, explores the benefits of propolis extract for adult patients with metabolic conditions. Conducted at RS Soerojo Magelang, a vertical hospital under Indonesia's Ministry of Health, it involved office workers aged 25-60, including those with obesity and diabetes.

Over 30 days, the research found that propolis supplement use maintains immune system balance without raising inflammation risk. Laboratory examinations showed acute-phase white blood cells more prepared for mild infections, while platelet and neutrophil profiles remained stable, and inflammation indicators did not increase.

At a press conference in Central Jakarta and the National Health Seminar titled 'Beyond the Fundamentals of Propolis Science: Clinical Evidence Behind HDI Propoelix' on Saturday, March 7, 2026, lead researcher Dr. H. Harli Amir Mahmudji, Sp.PD-KEMD, stated, "In chronic patients, the immune system remains balanced and inflammation risk does not increase." He emphasized, "This is a complement, not a replacement for medical therapy."

Dr. Muhamad Sahlan, S.Si., M.Eng., from Universitas Indonesia, added, "Propolis is one of the natural materials with very high complexity of bioactive compounds. The challenge is how to ensure standardization and scientific proof so it can be accepted in modern medical practice. Efforts like those by HDI are important to bridge basic science with clinical applications."

The researchers acknowledged the study's limitations, such as its short duration and limited participants, calling for further research with larger samples. Harli also highlighted the importance of balanced nutritious eating and regular exercise as primary ways to maintain immunity, with supplements serving only as adjuvants.

Liittyvät artikkelit

Lab illustration of sugarcane protein artificial saliva protecting tooth enamel in tests for cancer patients.
AI:n luoma kuva

Sugarcane-derived protein used in artificial saliva shows promise for protecting tooth enamel in lab tests

Raportoinut AI AI:n luoma kuva Faktatarkistettu

Researchers in Brazil report that an artificial-saliva formulation made with a lab-modified sugarcane protein, CaneCPI-5 (also written CANECPI-5), can bind to tooth enamel and help reduce bacterial activity and mineral loss in laboratory experiments designed to model the severe dental risks faced by head and neck cancer patients after radiotherapy. The work, published in the Journal of Dentistry, found the formulation performed best when combined with fluoride and xylitol.

Researchers at University College London have discovered how the body naturally shuts down inflammation using fat-derived molecules called epoxy-oxylipins. These molecules prevent the buildup of immune cells linked to chronic diseases like arthritis and heart disease. A study involving a drug that boosts these molecules showed faster pain relief and reduced harmful immune activity.

Raportoinut AI

Researchers at Tokyo University of Science have discovered that combining common plant compounds from mint, eucalyptus, and chili peppers dramatically enhances their anti-inflammatory effects in immune cells. Certain pairings amplified the response several hundred-fold compared to individual use. The findings, published in the journal Nutrients, suggest potential for new dietary approaches to combat chronic inflammation.

Building on genomic research linking Alzheimer's origins to inflammation in peripheral tissues like the gut, lungs, or skin, practical lifestyle measures can help curb chronic inflammation. These include vaccination, oral hygiene, diet, exercise, weight control, and stress management, offering benefits for overall health amid evolving science.

Raportoinut AI

Göteborgin yliopiston uusi tutkimus osoittaa, että tirzepatiidi, diabetes- ja laihduslääke Mounjaroon kuuluva vaikuttava aine, vähentää alkoholin kulutusta ja vastaavaa uudelleenpaluukäyttäytymistä rotilla ja hiirillä. Tämä perustuu aiempiin semaglutiidia Ozempicissä ja Wegovyssä koskeviin tutkimuksiin, jotka hillitsevät alkoholin kulutusta ihmisillä. Tutkijat toivovat samanlaisia vaikutuksia alkoholiriippuvuudesta kärsivillä potilailla.

Tämä verkkosivusto käyttää evästeitä

Käytämme evästeitä analyysiä varten parantaaksemme sivustoamme. Lue tietosuojakäytäntömme tietosuojakäytäntö lisätietoja varten.
Hylkää